Canadian Province Expands Biosimilar Switching, But Patient Group Voices Concerns

 
• By Aidan Fry
  
Cockpit
Patients with Crohn's disease and ulcerative colitis are to be switched to biosimilars in Canada's British Columbia province • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products